Smiths Group’s “Equal Weight” Rating Reaffirmed at Morgan Stanley (SMIN)
Smiths Group (LON:SMIN)‘s stock had its “equal weight” rating reiterated by equities research analysts at Morgan Stanley in a research note issued to investors on Thursday, StockRatingsNetwork reports.
Several other analysts have also recently commented on the stock. Analysts at Credit Suisse reiterated an “outperform” rating on shares of Smiths Group (LON:SMIN) in a research note to investors on Wednesday. They now have a GBX 1,460 ($23.56) price target on the stock. Separately, analysts at Deutsche Bank reiterated a “hold” rating on shares of Smiths Group (LON:SMIN) in a research note to investors on Monday. They now have a GBX 1,400 ($22.59) price target on the stock. Finally, analysts at RBC Capital reiterated an “underperform” rating on shares of Smiths Group (LON:SMIN) in a research note to investors on Thursday, September 26th. They now have a GBX 1,150 ($18.55) price target on the stock. Five analysts have rated the stock with a sell rating, eleven have issued a hold rating and nine have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of GBX 1,353.73 ($21.84).
Shares of Smiths Group (LON:SMIN) traded down 1.88% on Thursday, hitting GBX 1356.00. The stock had a trading volume of 948,778 shares. Smiths Group has a one year low of GBX 1018.00 and a one year high of GBX 1456.00. The stock’s 50-day moving average is GBX 1329. and its 200-day moving average is GBX 1311.. The company’s market cap is £5.340 billion.
Smiths Group plc is a technology company. It has five divisions: Smiths Detection, Smiths Medical, John Crane, Smiths Interconnect and Flex-Tek.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.